Berkeley Lights
Berkeley Lights Revenues Rise 9 Percent in Q1 2022
The firm reported revenue growth alongside increased operating expenses and a jump in its net loss.
Stocks of Omics Tools, MDx Firms Find More Stable Footing in February After Tough Start to Year
The GenomeWeb Top 40 was flat during February while the Dow Jones, Nasdaq, and Nasdaq Biotechnology Index posted modest declines.
Berkeley Lights Q4 Revenues Grow 7 Percent
The company's full-year 2021 revenues grew 33 percent, driven largely by robust strategic partnerships and services, and strong sequential recurring revenue.
Stocks of Genomics Tools and MDx Firms Hit Hard in January Sell-off
While the broader stock market has experienced a sharp downturn to start the year, firms in the omics research tools and molecular diagnostics space were hit particularly hard.
JPM Healthcare Conference Day 2: Thermo Fisher, BD, SomaLogic, Myriad, Oxford Nanopore, More
Highlights of the second day included Myriad Genetics' new oncology testing service and more details on SomaLogic's partnership with Illumina.
Nov 4, 2021
Berkeley Lights Revenues Grow 34 Percent in Q3
Aug 11, 2021
May 12, 2021
May 11, 2021
Berkeley Lights Q1 Revenues Grow 35 Percent
Feb 25, 2021
Berkeley Lights Q4 Revenues Rise 31 Percent
Nov 12, 2020